EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma

Rui-Chao Chai iD, Hao Yan, Song-Yuan An, Bo Pang, Hui-Yuan Chen iD, Quan-Hua Mu, Ke-Nan Zhang, Yao-Wu Zhang, Yu-Qing Liu, Xing Liu, Zheng Zhao, Tao Jiang und 2 weitere

Brain Pathology · 2023-07 · 33 (4)

DOI: 10.1111/bpa.13153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 07.02.2023. Verfasst von Rui-Chao Chai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Spinal Cord Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Nova Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

H3 K27‐altered diffuse midline glioma is a highly lethal pediatric‐type tumor without efficacious treatments. Recent findings have highlighted the heterogeneity among diffuse midline gliomas with different locations and ages. Compared to tumors located in the brain stem and thalamus, the molecular and clinicopathological features of H3 K27‐altered spinal cord glioma are still largely elusive, thus hindering the accurate management of patients. Here we aimed to characterize the clinicopathological and molecular features of H3 K27M‐mutant spinal cord glioma in 77 consecutive cases. We found that the H3 K27M‐mutant spinal cord glioma, with a median age of 35 years old, had a significantly better prognosis than H3 K27M‐mutant brain tumors. We noticed a molecular heterogeneity of H3 K27M‐mutant spinal cord astrocytoma via targeted sequencing with 34 cases. TP53 mutation which occurred in 58.8% of cases is mutually exclusive with PPM1D (26%) and NF1 (44%) mutations. The TP53 ‐mutant cases had a significantly higher number of copy number variants (CNV) and a marginally higher proportion of pediatric patients (age at diagnosis 10%) are associated with a worse prognosis. Interestingly, the histological type, an independent prognostic factor in multivariate Cox regression, can also stratify molecular features of H3 K27M‐mutant spinal cord glioma, including the RB pathway, KRAS/PI3K pathway, and chromosome arms CNV. In conclusion, although all H3 K27M‐mutant spinal cord diffuse glioma were diagnosed as WHO Grade 4, the histological type, molecular features representing chromatin instability, and molecular alterations associated with accelerated cell proliferative activity should not be ignored in clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsSpinal Cord NeoplasmsHumansChildAdultAdolescentHistonesPrognosisPhosphatidylinositol 3-KinasesMutationGenomics

Stichwörter der Autor:innen

H3 K27M mutationintramedullary tumormidline gliomamolecular pathologyspinal cord glioma

Substanzen

HistonesPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, SAR, China.

ORCID-Profile: Rui-Chao Chai, Hui-Yuan Chen, Yong-Zhi Wang

Förderung

  • Beijing Nova Program
  • National Natural Science Foundation of China

Zitieren

APA

Chai, R. C., Yan, H., An, S. Y., Pang, B., Chen, H. Y., Mu, Q. H., Zhang, K. N., Zhang, Y. W., Liu, Y. Q., Liu, X., Zhao, Z., Jiang, T., Wang, Y. Z., & Jia, W. Q. (2023). Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma. Brain Pathology, 33(4). https://doi.org/10.1111/bpa.13153

Vancouver

Chai RC, Yan H, An SY, Pang B, Chen HY, Mu QH, et al. Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma. Brain Pathology. 2023;33(4). doi:10.1111/bpa.13153

BibTeX
@article{Chai2023,
  author = {Chai, Rui-Chao and Yan, Hao and An, Song-Yuan and Pang, Bo and Chen, Hui-Yuan and Mu, Quan-Hua and Zhang, Ke-Nan and Zhang, Yao-Wu and Liu, Yu-Qing and Liu, Xing and Zhao, Zheng and Jiang, Tao and Wang, Yong-Zhi and Jia, Wen-Qing},
  title = {Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma},
  journal = {Brain Pathology},
  year = {2023},
  volume = {33},
  number = {4},
  doi = {10.1111/bpa.13153}
}
Kostenlos starten →